Anu Thummala

Articles by Anu Thummala

TPS 38 ELCIN: Elacestrant in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer: An Open-Label, Multicenter, Phase 2 Study

ByVirginia Kaklamani, MD, DSc,Giorgi Dzagnidze,Nicoleta Zenovia Antone,Anu Thummala,Mikheil Janjalia,Patricia Santi,Carlos Barrios,Mehmet Ali Nahit Sendur,Xiaoling Zhang,Angela Gambioli,Manuel Dominguez,Kathy Puyana Theall,Tomer Wasserman,William J Gradishar, MD, FASCO, FACP

June 12th 2025

Latest Updated Articles

Trending on CancerNetwork

FDA Approves SC Amivantamab for Recurrent/Metastatic HNSCC

FDA Sets PDUFA Date for Rivoceranib/Camrelizumab Resubmission After Third CRL in Unresectable HCC

Sacituzumab Govitecan Efficacy, Safety Debated in First-Line Metastatic TNBC

Air Pollution Emerges as Second Leading Risk Factor for Lung Cancer Deaths

Where Does Prostate Brachytherapy Fit Best in the Treatment Paradigm?